[
    "{\"step_by_step_thinking\": \"Gp IIb/IIIa inhibitors are a class of medications used in the treatment of acute coronary syndromes and during percutaneous coronary intervention (PCI). They work by inhibiting the platelet glycoprotein IIb/IIIa receptor, which is involved in platelet aggregation. Prasugrel, Abciximab, Tirofiban, and Eptifibatide are all Gp IIb/IIIa inhibitors. Therefore, the answer is none of the above options.\", \"answer_choice\": \"None of the above\"}"
]